Table 1.
Nanomaterials | Cell Lines | Dose (µg• mL−1) |
References | Nanomaterials | Cell Lines | Dose (µg• mL−1) |
References |
---|---|---|---|---|---|---|---|
Cu3BiS3 | 4T1 | 200 | 29 | Bi | HeLa | 500 | 18 |
HeLa MCF-7 |
200 | 44 | U937 HepG2 |
10,000 | 37 | ||
HUVEC* BEL-7402 |
100 | 45 | MCF-7 SMMC-7721 VSMC |
400 | 46 | ||
HeLa L929* |
200 | 31 | 4T1 HUVEC* |
200 | 47 | ||
HeLa | 600 | 5 | U14 | 500 | 1 | ||
MCF-7 | 150 | 48 | 4T1 L02* |
400 | 32 | ||
HeLa | 200 | 49 | 4T1 NIH-3T3 HUVEC |
160 | 50 | ||
Bi2Se3 | 4T1 3T3* |
200 | 26 | HeLa MCF-7 |
500 | 34 | |
MCF-7 | 200 | 51 | HeLa | 600 | 23 | ||
HeLa HUVEC* |
400 | 3 | HeLa HUVEC* |
300 | 4 | ||
H22 | 200 | 52 | 4T1 | 100 | 53 | ||
BEL-7402 | 100 | 7 | HeLa | 400 | 30 | ||
HeLa | 200 | 8 | Bi2S3 | 4T1 | 300 | 24 | |
HeLa | 200 | 54 | 4T1 | 160 | 28 | ||
BiFe | BJ5ta* HepG2 |
100 | 27 | HeLa HUVEC* |
300 | 2 | |
HeLa MCF-7 |
500 | 34 | 4T1 J774 |
15,000 | 55 | ||
HepG2 | 3000 | 10 | HeLa | 7500 | 41 | ||
Bi2S3/Au | 4T1 MCF-7 |
100 | 56 | Bi2S3/G | HUVEC* HeLa MCF-7 HepG2 BEL-7402 |
40 | 6 |
FeSe2/Bi2S3 | 4T1 | 200 | 9 | PC3 | 200 | 25 | |
BiSe/G | HeLa | 150 | 33 | BiOCl | MCF-7 | 200 | 57 |
GdBi | C6 COS-7* |
200 | 58 | L929 | 500 | 59 | |
Bi2WO6 | HeLa | 800 | 11 | Bi2O3:Yb3+/Er3+ | HeLa | 1000 | 60 |
HUVE HeLa |
400 | 61 | Bi2S3/FeS2 | 4T1 | 800 | 62 | |
GBi | HeLa MCF-7 |
500 | 35 | BiOI | HeLa | 4200 | 63 |
BMS | HUVE HeLa |
200 | 64 | 4T1 HeLa |
200 | 65 | |
K0.3Bi0.7F2.4 | HeLa | 500 | 66 | (BiO)2CO3 | Huh-7 | 5mM | 48 |
BiOBr | L929 | 1000 | 67 | Bi2S3-MnO2 | U14 | 10 | 68 |
AgBiS2 | UMR-106 | 500 | 69 | BPZP | 4T1 | 100 | 70 |
Note: * The cells are non-cancer cells.
Abbreviations: 3T3, mouse embryonic fibroblast; 4T1, breast cancer cell; AgBiS2 NPs, silver bismuth sulfide; BEL-7402, liver carcinoma cell; BJ5ta, human fore skin fibroblast; Bi, pure bismuth; Bi2S3, bismuth sulfide; Bi2Se3, bismuth selenide; Bi2S3/Au, bismuth sulfide-gold; Bi2S3/G, bismuth sulfide-graphene; Bi2S3-MnO2 NPs, bismuth sulfide and manganese oxide nanocomposites; Bi2WO6, bismuth tungstate; BiFe, bismuth ferrite; (BiO)2CO3, bismuth subcarbonate; BiOBr, bismuth oxybromide; BiOCl, bismuth oxychloride; BiOI, bismuth oxyiodide; BMS NRs, bismuth sulfide -mesoporous silica; BPZP, bismuth sulfide-linked zinc protoporphyrin; BiSe/G, bismuth selenide-graphene; C6, glioma cell; COS-7, monkey kidney fibroblasts; Cu3BiS3, copper bismuth sulfide; FeSe2/Bi2S3, iron diselenide-bismuth selenide; GBi, graphene-bismuth; GdBi, gadolinium-bismuth; H22, hepatic carcinoma cell; HeLa, cervical cancer cell; HepG2, hepatic carcinoma cell; Huh-7, human liver cell; HUVEC, human umbilical vein endothelial cell; J774, Mus muscles reticulum cell sarcoma; L02, human hepatic cell; L929, murine fibroblast cell; MCF-7, breast cancer cell; PC3, human prostate carcinoma; SMMC-7721, hepatic carcinoma cell; U14, cervical carcinoma cell; U937, macrophage cells; VSMC, vascular smooth muscle cell.